SARS-CoV-2 (COVID-19) Envelope protein, GST,His Tag

ユーザーレビュー
製品番号/仕様
価格
数量
ENN-C5128-100ug
$360.00
ENN-C5128-1mg (200ug X 5)
$2615.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    Envelope protein, Env polyprotein, Envelope glycoprotein, env

  • Source

    SARS-CoV-2 Envelope protein, GST,His Tag (ENN-C5128) is expressed from E. coli cells. It contains AA Met 1 - Val 75 (Accession # QHU79206.1).

    Predicted N-terminus: Met

    Request for sequence
  • Molecular Characterization

    Envelope protein Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a GST tag at the N-terminus and a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 36.8 kDa. The protein migrates as 33-35 kDa under reducing (R) condition (SDS-PAGE).

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 20 mM Tris, Arginine, pH8.0 with sucrose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    Envelope protein SDS-PAGE

    SARS-CoV-2 Envelope protein, GST,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

ユーザーレビュー
コメントを投稿

バックグランド

The SARS-CoV-2 is composed of a double-layered lipid envelope, including Spike glycoprotein (S), Envelope protein (E), Membrane glycoprotein (M), and Nucleocapsid protein (Nucleocapsid protein, N). Among them, The amino acid sequence of the SARS-CoV-2 envelope protein is 95% identical of the SARS envelope protein.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Recombinant envelope protein

  • カテゴリ:

  • 市販の医薬品数:

    1 詳細

  • 治験医薬品数:

    6 詳細

  • 最新の開発ステージ:

    Approved

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8